FIGURE

Figure 4

ID
ZDB-FIG-210617-68
Publication
Kim et al., 2021 - A Screening of the MMV Pandemic Response Box Reveals Epetraborole as a New Potent Inhibitor against Mycobacterium abscessus
Other Figures
All Figure Page
Back to All Figure Page
Figure 4

ZF In vivo efficacy of ETB. (A) Different concentrations of ETB (6.25, 12.5, 25, and 50 µM) and TGC (50 µM) were treated to the ZF infected with MabR-mWasabi and proliferation or reduction of mWasabi signal in ZF was monitored under the fluorescent microscope. After antibiotics treatment, the bacterial burden of infected ZF was quantified through traditional agar plate quantification method. Data was expressed as the mean log10 CFU per embryo (n = 10 of each condition) from three independent experiments. (B) All infected fishes treated at 6.25, 12.5, 25, and 50 µM of ETB and TGC (50 µM). Survival curve was plotted from MabR-mWasabi infected ZF for 13 days. (n = 20, representative of three independent experiments). Survival curves were compared with the log-rank (Mantel-Cox) test (* p < 0.05, ** p < 0.01; *** p < 0.001; ns: Not significant). Inf UNT: Infected but not treated control.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Condition:
Observed In:
Stage: Days 7-13

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Mol. Sci.